← Open Payments lookup

FERNANDO LOPEZ: Open Payments

NPI 1659391951 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,622 in 144 payments from 15 companies in 2025. Trend: 2023 $2,698 · 2024 $3,200 · 2025 $3,622

Food & beverage: $3,622
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$804
Alkermes, Inc.15$427
Otsuka America Pharmaceutical, Inc.16$363
E.R. Squibb & Sons, L.L.C.23$338
ABBVIE INC.13$326
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)13$307
Vanda Pharmaceuticals Inc.9$307
Axsome Therapeutics, Inc.12$297
Janssen Pharmaceuticals, Inc11$256
Teva Pharmaceuticals USA, Inc.6$117

Products named: INGREZZA, COBENFY, VRAYLAR, CAPLYTA, FANAPT, ARISTADA, Auvelity, INVEGA SUSTENNA.

Industry payments across AL — which companies pay providers there.